Visual explainers

Bone Health Visual Explainers

Some bone-health ideas make more sense when you can see the sequence. These simple visual maps explain what can happen after a fracture, how bone remodeling works, how a DXA report becomes a clinical conversation, and how medication categories fit into fracture prevention.

Sign up once for download access: Please sign up for the BonegevityMD newsletter before using the Starter Kit or fact sheet downloads. Already signed up? Open the Download Library.

After a low-energy fracture

1FractureA fall from standing height or a minor trauma fracture may be a bone-health signal, especially after midlife.
2Repair the injuryThe immediate fracture care matters first: pain control, alignment, surgery when needed, and safe motion.
3Ask whyThe next question is whether bone strength, medications, falls, vitamin D, or other conditions contributed.
4Prevent the next oneDXA, labs, fall prevention, nutrition, strength, and medication discussions can become part of the plan.

Fracture liaison service research supports systematic follow-up after fragility fracture because the first fracture is often a chance to prevent the next one.1,2

Open the fracture pathway

Bone remodeling in one picture

Remove old boneOsteoclasts resorb microscopic areas of old or damaged bone.
Build new boneOsteoblasts lay down new bone matrix that later mineralizes.
Keep balanceHealthy remodeling keeps repair and renewal in balance. Aging, menopause, inflammation, medications, and illness can shift that balance.

Bone is living tissue. It is not a fixed piece of architecture. Remodeling is one reason hormones, medications, nutrition, kidney function, inflammation, strength training, and falls can all matter to fracture prevention.

How a DXA report becomes a care conversation

1MeasureThe scan measures BMD at sites such as spine, femoral neck, total hip, or forearm.
2ClassifyThe report may include normal bone density, low bone mass, osteoporosis, or age-matched language.
3ContextPrior fracture, falls, medications, and medical history can change the meaning of the number.
4PlanThe clinician decides whether labs, spine imaging, nutrition, exercise, medications, or follow-up DXA should be discussed.

DXA is useful because it gives reproducible BMD data, but fracture risk is broader than density alone.5,6

Open the DXA report explainer

Medication categories without the fog

Antiresorptive medicinesThese slow bone breakdown. Bisphosphonates and denosumab are common examples. The conversation often includes route, duration, kidney function, dental history, and rare side effects.
Anabolic medicinesThese help build bone. They may be discussed for higher-risk situations, very low BMD, or some patients with fractures. Timing and what comes after treatment matter.
Hormone-related optionsSome options affect estrogen pathways. These require individualized discussion around menopause symptoms, clot risk, breast cancer history, uterus status, and age/timing.
Not a shortcutMedication choices should fit the person, the fracture history, the DXA report, labs, preferences, and risk tolerance.

Major osteoporosis reviews emphasize combining pharmacologic and nonpharmacologic strategies rather than treating medication as the whole plan.7

Printable helpers

Questions after a fragility fractureBring this to a fracture follow-up or primary care visit.How to read your DXA reportUse this while reviewing a bone density report.Bone health nutrition snapshotOrganize calcium, vitamin D, protein, and food questions.Medication discussion checklistPrepare for a thoughtful medication conversation.

References

  1. Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL. Coordinating multidisciplinary care: improving outcomes after fragility fractures. N Engl J Med. 2025;392(4):379-391. doi:10.1056/NEJMra2304245.
  2. Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL. Coordinating multidisciplinary care: improving outcomes after fragility fractures. N Engl J Med. 2025;392(4):379-391. doi:10.1056/NEJMra2304245.
  3. Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393(10169):364-376. doi:10.1016/S0140-6736(18)32112-3.
  4. El Maghraoui A, Roux C. DXA scanning in clinical practice. QJM. 2008;101(8):605-617. doi:10.1093/qjmed/hcn022.
  5. El Maghraoui A, Roux C. DXA scanning in clinical practice. QJM. 2008;101(8):605-617. doi:10.1093/qjmed/hcn022.
  6. Licata AA, Binkley N, Petak SM, Camacho PM. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the quality of DXA scans and reports. Endocr Pract. 2018;24(2):220-229. doi:10.4158/CS-2017-0081.
  7. Morin SN, Leslie WD, Schousboe JT. Osteoporosis: a review. JAMA. 2025. doi:10.1001/jama.2025.6003.

Educational Use Only

This website is educational. It is not a medical practice, telemedicine service, or a substitute for care from your own clinician.